SARS-CoV-IN-3

Modify Date: 2024-01-09 16:13:09

SARS-CoV-IN-3 Structure
SARS-CoV-IN-3 structure
Common Name SARS-CoV-IN-3
CAS Number 888958-27-8 Molecular Weight 469.74
Density N/A Boiling Point N/A
Molecular Formula C25H20ClFeN3O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SARS-CoV-IN-3


SARS-CoV-IN-3 is an effective inhibitor of SARS-CoV replication. SARS-CoV-IN-3 shows anti-Coronavirus activity with an EC50 of 3.6 μM in Vero cells. SARS-CoV-IN-3 inhibits the 3D7 and W2 strains of P. falciparum with IC50s of 11.7 and 20.4 nM; and IC90s of 29.19 and 56 nM; respectively. SARS-CoV-IN-3 reduces HIV-1-induced cytopathic effect with an EC50 of 10 μM in MT-4 cells[1].

 Names

Name SARS-CoV-IN-3

 SARS-CoV-IN-3 Biological Activity

Description SARS-CoV-IN-3 is an effective inhibitor of SARS-CoV replication. SARS-CoV-IN-3 shows anti-Coronavirus activity with an EC50 of 3.6 μM in Vero cells. SARS-CoV-IN-3 inhibits the 3D7 and W2 strains of P. falciparum with IC50s of 11.7 and 20.4 nM; and IC90s of 29.19 and 56 nM; respectively. SARS-CoV-IN-3 reduces HIV-1-induced cytopathic effect with an EC50 of 10 μM in MT-4 cells[1].
Related Catalog
Target

EC50: 3.6 μM (SARS-CoV, in Vero cells)[1] IC50: 11.7 nM (3D7 P. falciparum), 20.4 nM (W2 P. falciparum)[1] IC90: 29.19 nM (3D7 P. falciparum), 56 nM (W2 P. falciparum)[1]

In Vitro SARS-CoV-IN-3 (Compound 4) inhibits in vitro growth of Plasmodium falciparum far better than Chloroquine (CQ) [1].
References

[1]. Biot C, et al. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006 May 4;49(9):2845-9.

 Chemical & Physical Properties

Molecular Formula C25H20ClFeN3O
Molecular Weight 469.74